Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

Apafant effective in UVB-induced dermatitis

July 16, 2003

Barrier Therapeutics licenses oral vitamin D3 derivative

July 15, 2003

Selective MMP-3 inhibitor as a candidate therapeutic for chronic dermal wounds

July 10, 2003

Amgen/Wyeth seek approval for fifth indication for anti-TNF therapy

July 9, 2003

GSK develops new glucocorticoid receptor agonists

July 9, 2003

Novel vitamin D analogues with utility in dermatological disorders designed at Galderma

July 8, 2003

Connetics submits NDA for Extina in seborrheic dermatitis

July 7, 2003

Liarozole granted E.U. orphan drug designation for congenital ichthyosis

July 4, 2003

Olux cleared for marketing in U.K.

July 3, 2003

Positive outcome for phase II study of Periostat as adjunctive treatment for rosacea

July 3, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.